Terns Pharmaceuticals, Inc.
TERN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $151 | $146 | $139 | $161 |
| Short-Term Investments | $145 | $169 | $195 | $197 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $4 | $3 | $4 |
| Total Curr. Assets | $300 | $319 | $338 | $362 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $302 | $320 | $339 | $364 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $3 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $12 | $10 | $8 | $13 |
| Total Curr. Liab. | $15 | $13 | $11 | $16 |
| LT Debt | $1 | $1 | $1 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $2 | $1 |
| Total NC Liab. | $2 | $2 | $2 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $18 | $15 | $13 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$494 | -$469 | -$445 | -$421 |
| AOCI | $0 | -$0 | $0 | -$0 |
| Other Equity | $778 | $775 | $771 | $768 |
| Total Equity | $284 | $305 | $326 | $346 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $302 | $320 | $339 | $364 |
| Net Debt | -$150 | -$145 | -$138 | -$160 |